These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12485939)

  • 1. Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype.
    Schroeder V; Kohler HP
    Blood; 2003 Jan; 101(1):371-2; author reply 372. PubMed ID: 12485939
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin hydrolysis of V29F and V34L mutants of factor XIII (28-41) reveals roles of the P(9) and P(4) positions in factor XIII activation.
    Trumbo TA; Maurer MC
    Biochemistry; 2002 Feb; 41(8):2859-68. PubMed ID: 11851434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activation of factor XIII by beta-thrombin].
    Umarova BA; Strukova SM
    Biokhimiia; 1979 Aug; 44(8):1524-9. PubMed ID: 497297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombomodulin inhibits the activation of factor XIII by thrombin.
    Polgár J; Léránt I; Muszbek L; Machovich R
    Thromb Res; 1986 Sep; 43(5):685-90. PubMed ID: 3018957
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency.
    Wilmer M; Rudin K; Kolde H; Poetzsch B; Lenz W; Moessmer G; Meili E; Egbring R; Gempeler-Messina P; Gempeler M; Bastian S; Kohler H
    Thromb Res; 2001 Apr; 102(1):81-91. PubMed ID: 11323018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
    Isetti G; Maurer MC
    Biochemistry; 2007 Mar; 46(9):2444-52. PubMed ID: 17286389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Val34Leu and Val35Leu polymorphism on the enzyme activity of the coagulation factor XIII-A.
    Lee IH; Chung SI; Lee SY
    Exp Mol Med; 2002 Nov; 34(5):385-90. PubMed ID: 12526104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fibrinogen and Ca2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII.
    Shafer JA; Lewis SD; Janus TJ; Lorand L
    Ann N Y Acad Sci; 1986; 485():134-9. PubMed ID: 3471144
    [No Abstract]   [Full Text] [Related]  

  • 11. [Activation of plasma Factor XIII by acetylated thrombin].
    Orlova AS; Baskova IP
    Biokhimiia; 1977 Feb; 42(2):297-9. PubMed ID: 856308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site.
    Trumbo TA; Maurer MC
    Thromb Haemost; 2003 Apr; 89(4):647-53. PubMed ID: 12669118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 14. The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma.
    Shemirani AH; Haramura G; Bagoly Z; Muszbek L
    Biochim Biophys Acta; 2006 Aug; 1764(8):1420-3. PubMed ID: 16920044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarction.
    Kohler HP; Grant PJ
    Thromb Haemost; 1998 Nov; 80(5):862. PubMed ID: 9843187
    [No Abstract]   [Full Text] [Related]  

  • 16. The binding of divalent metal ions to platelet factor XIII modulates its proteolysis by trypsin and thrombin.
    Mary A; Achyuthan KE; Greenberg CS
    Arch Biochem Biophys; 1988 Feb; 261(1):112-21. PubMed ID: 2893589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography.
    Warner D; Mansfield MW; Grant PJ
    Thromb Haemost; 2001 Mar; 85(3):408-11. PubMed ID: 11307805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen.
    Krarup A; Gulla KC; Gál P; Hajela K; Sim RB
    Biochim Biophys Acta; 2008 Sep; 1784(9):1294-300. PubMed ID: 18456010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.
    Yee VC; Pedersen LC; Bishop PD; Stenkamp RE; Teller DC
    Thromb Res; 1995 Jun; 78(5):389-97. PubMed ID: 7660355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.